Good morning :)
Fortis Healthcare Ltd

Fortis Healthcare Ltd

FORTIS Share Price

NSE
₹766.906.45% (-52.90)
High
—
—
Low
—
—
Returns
—
—
Loading...
1D
1W
1M
3M
6M
1Y
3Y
5Y
Max
SIP

FORTIS Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Avg

Financials growth has been moderate for a few years

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

FORTIS Performance & Key Metrics

FORTIS Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
55.765.690.13%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
44.365.940.49%

FORTIS Analyst Ratings & Forecast

Detailed Forecast Detailed Forecast 
90%
Analysts have suggested that investors can buy this stock

from 20 analysts

Price Upside

Earnings Growth

Rev. Growth

See Detailed Forecast

FORTIS Company Profile

Fortis Healthcare Limited is an integrated healthcare delivery service provider. The Company is engaged in establishing, administering hospitals, diagnostic centers and research centers.

Investor Presentation

View older View older 

Nov 5, 2026

PDF
View Older Presentations

FORTIS Similar Stocks (Peers)

Compare with peers Compare with peers 

FORTIS Similar Stocks (Peers)

Compare with peers Compare with peers 
PE Ratio
61.70
61.70
1Y Return
8.53%
8.53%
Buy Reco %
86.67
86.67
PE Ratio
61.26
61.26
1Y Return
17.01%
17.01%
Buy Reco %
84.62
84.62
PE Ratio
89.54
89.54
1Y Return
3.04%
3.04%
Buy Reco %
66.67
66.67
PE Ratio
151.38
151.38
1Y Return
3.77%
3.77%
Buy Reco %
91.67
91.67
PE Ratio
45.38
45.38
1Y Return
4.57%
4.57%
Buy Reco %
91.67
91.67
Compare with Peers

FORTIS Sentiment Analysis

FORTIS Sentiment Analysis

New
Crisp summary & key insights to decode earnings calls instantly

FORTIS Stock Summary · August 2026

Management struck a constructive but measured tone, saying the quarter marked a steady start to FY27 with solid growth across both hospitals and diagnostics. Consolidated revenue rose 17.5% year over year to INR 2,545 crores, while operating EBITDA before ESOP expenses increased 15.8% to INR 568 crores, even as the margin eased slightly to 22.3% from 22.6%. In hospitals, occupancy held at 69% and occupied beds increased 17% to 3,418, supported by acquisitions and higher utilization, while ARPOB improved 2.6%; management also noted that newer assets in Punjab, Bengaluru and Delhi NCR diluted margins temporarily, though like-for-like performance remained broadly stable. Growth was led by core specialties and a richer profitability mix, with 14 facilities now generating EBITDA margins above 20%. Management emphasized expansion through brownfield and greenfield additions, oncology investments, and robotics, while keeping debt at a manageable 1.01x net debt-to-EBITDA. Looking ahead, it reiterated a 25% EBITDA margin target over the next two years despite ESOP costs, and guided diagnostics to about 12% to 13% revenue growth with margins of 24% to 25%.

FORTIS Stock Growth Drivers
FORTIS Stock Growth Drivers
8
  • Strong Consolidated Revenue and EBITDA Growth

    The company delivered a solid start to FY27 with consolidated revenue rising 17.5% year over

  • Hospital Network Growth and Specialty-Led Demand

    The hospital business showed strong underlying momentum, with revenue growth of 19% and steady occupancy

FORTIS Stock Challenges
FORTIS Stock Challenges
3
  • Hospital margin pressure from ESOP, legal costs, and doubtful debt provisions

    Hospital profitability was pressured by multiple near-term cost and credit headwinds. Segment EBITDA margin declined

  • Delayed collections increasing credit risk and working-capital drag

    Collections from government payors and certain TPAs have slowed, leading to a higher provision for

FORTIS Forecast

FORTIS Forecasts

Price

Revenue

Earnings

FORTIS

FORTIS

Income

Balance Sheet

Cash Flow

FORTIS Income Statement

FORTIS Income Statement

Loading...

Quarterjun 2024sep 2024dec 2024mar 2025jun 2025sep 2025dec 2025mar 2026jun 2026sep 2026
Total Revenue1,872.702,005.861,975.012,031.642,197.672,381.232,276.832,375.282,573.412,750.58
Operating & Other expensessubtract1,516.381,613.331,553.141,625.301,676.051,775.111,805.271,844.832,007.912,111.64
Depreciation/Amortizationsubtract91.0095.0597.33102.23101.48105.84120.14121.97121.88128.33
Interest & Other Itemssubtract35.2736.4345.1567.5669.5774.8885.7484.2880.4478.30
Taxes & Other Itemssubtract64.0984.5931.4952.6690.29103.4871.9558.3596.79119.93
EPS2.202.343.282.443.454.262.573.523.534.14

FORTIS Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2027FY 2027

Annual Report Pending

Investor Presentation

Nov 5PDF
Aug 6PDF
FY 2026FY 2026

Annual report

PDF

Investor Presentation

May 22PDF
Feb 13PDF
Nov 11PDF
Aug 6PDF
FY 2025FY 2025

Annual report

PDF

Investor Presentation

May 20PDF
Feb 7PDF
Nov 8PDF
FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 4PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
 

FORTIS Stock Peers

FORTIS Past Performance & Peer Comparison

FORTIS Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CareHospitals & Diagnostic Centres

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Fortis Healthcare Ltd54.675.690.13%
Apollo Hospitals Enterprise Limited61.7012.170.24%
Max Healthcare Institute Limited61.268.460.21%
Manipal Health Enterprises Limited89.549.67—
ScreenerCompare valuation on Screener

FORTIS Stock Price Comparison

Compare FORTIS with any stock or ETF
Compare FORTIS with any stock or ETF
FORTIS
Loading...

FORTIS Holdings

FORTIS Shareholdings

FORTIS Promoter Holdings Trend

FORTIS Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

FORTIS Institutional Holdings Trend

FORTIS Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Decreased Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has decreased by 2.00%

Tickertape Separator

FORTIS Shareholding Pattern

FORTIS Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding31.17%26.94%7.52%23.19%11.18%

Dec 2025

Mar 2026

Jun 2026

Sep 2026

FORTIS Shareholding History

FORTIS Shareholding History

JunSepDec '25MarJunSep27.17%27.90%27.84%25.97%25.20%23.19%

Mutual Funds Invested in FORTIS

Mutual Funds Invested in FORTIS

No mutual funds holding trends are available

Top 5 Mutual Funds holding Fortis Healthcare Ltd




Funds (Top 5)Market-cap heldWeight3M holding changePortfolio rank
(3M change)
4.2161%2.40%-0.68%10/81 (-4)
4.0113%3.49%-0.49%2/78 (-1)
2.1944%2.53%-0.13%4/104 (-2)

Compare 3-month MF holding change on Screener

FORTIS Insider Trades & Bulk Stock Deals

FORTIS Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing FORTIS stock

smallcases containing FORTIS stock

Looks like this stock is not in any smallcase yet.

FORTIS Events

FORTIS Events

FORTIS Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

FORTIS Dividend Trend

No dividend trend available

FORTIS Upcoming Dividends

FORTIS Upcoming Dividends

No upcoming dividends are available

FORTIS Past Dividends

FORTIS Past Dividends

Cash Dividend

Ex DateEx DateJul 24, 2026

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 24, 2026

Cash Dividend

Ex DateEx DateJul 25, 2025

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 25, 2025

Cash Dividend

Ex DateEx DateJul 24, 2024

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 24, 2024

Cash Dividend

Ex DateEx DateJul 20, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 20, 2023

FORTIS Stock News & Opinions

FORTIS Stock News & Opinions

Earnings
Earnings
Fortis Healthcare Ltd consolidated sales up 7.46% on year in Q3FY2026, net profit expanded by 17.47%

Fortis Healthcare Ltd share price ticked higher by 3.68% to Rs 820.0 after the company's net profit rose by 17.47% to Rs 320.47 crore, while revenue from operations slightly gained 7.46% to Rs 2734.83 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.82 lakh crore, gaining 8.72%. It has inched up 4.19% over last one week and dipped slightly by 7.60% in last one month while the market capitalization of Fortis Healthcare Ltd has marginally improved by 6.52% and 14.58% in the same period respectively. Profit before tax (PBT) of Fortis Healthcare Ltd stood at Rs 432.31 crore in Q3 FY26, rising 1.62% year-on-year, and rallying 19.03% quarter-on-quarter. EBITDA came in at Rs 616 crore, surging by 15.50% YoY and expanding by 17.95% sequentially. Total expenses grew marginally by 5.17% to Rs 2239.97 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 600.79 crore, posting a minor increase of 2.60% YoY, while employee benefits expense was at Rs 408.97 crore, ticking higher by 1.12% YoY. For the TTM ended FY26, revenue from operations advanced 17.28% to Rs 9127.84 crore, while net profit jumped 31.48% to Rs 1064.19 crore, compared to previous TTM. EBITDA soared by 158382% to Rs 2034.32 crore, and PBT surged 35.63% to Rs 1365.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1601.46 crore in FY26, as against Rs 1423.93 crore in FY25. Fortis Healthcare Ltd tumbled by 18.84% in last one year, underperforming the benchmark BSE Sensex which has slipped by 4.80% during the same period.

1 day agoCapital Market - Live
Earnings
Earnings
Fortis Healthcare Ltd consolidated sales up 7.46% on year in Q3FY2026, net profit improved by 17.47%

Fortis Healthcare Ltd share price ticked higher by 3.68% to Rs 820.0 after the company's net profit rose by 17.47% to Rs 320.47 crore, while revenue from operations improved marginally 7.46% to Rs 2734.83 crore in Q3FY26 over Q2FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 6.82 lakh crore, easing 8.77%. It has inched up 5.63% over last one week and eased lower by 7.60% in last one month while the market capitalization of Fortis Healthcare Ltd has marginally improved by 8.82% and 14.58% in the same period respectively. Profit before tax (PBT) of Fortis Healthcare Ltd stood at Rs 432.31 crore in Q3 FY26, gaining 1.62% year-on-year, and rallying 19.03% quarter-on-quarter. EBITDA came in at Rs 616 crore, surging by 15.50% YoY and jumping 17.95% sequentially. Total expenses saw a slight increase of 5.17% to Rs 2239.97 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 600.79 crore, posting a minor increase of 2.60% YoY, while employee benefits expense was at Rs 408.97 crore, inching up 1.12% YoY. For the TTM ended FY26, revenue from operations improved 17.28% to Rs 9127.84 crore, while net profit surged by 31.48% to Rs 1064.19 crore, compared to previous TTM. EBITDA jumped by 158382% to Rs 2034.32 crore, and PBT surged 35.63% to Rs 1365.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1601.46 crore in FY26, as against Rs 1423.93 crore in FY25. Fortis Healthcare Ltd nosedived by 22.35% in last one year, underperforming the benchmark BSE Sensex which has eased by 7.38% during the same period.

2 days agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare to review financial results and debenture terms at November meeting

Fortis Healthcare Limited will hold a board meeting on November 5, 2026, to consider and approve the un-audited financial results (standalone & consolidated) for the quarter and half year ended September 30, 2026, and to consider alteration of rights of debenture holders and alteration in the terms of the debentures including the date of interest for its existing 1,55,000 listed, senior, unsecured, rated, redeemable Non-Convertible Debentures with a face value of Rs 1,00,000 each and an aggregate value of up to Rs 1550,00,00,000.

1 week agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare acquires Suguna Ramaiah Hospitals for roughly Rs 277 crore in Bengaluru

Fortis Healthcare Limited announced that its wholly-owned subsidiary, International Hospital Limited, has completed the acquisition of Suguna Ramaiah Hospitals Private Limited and the land and building of Suguna Hospital in Bengaluru for approximately Rs 277 crore. The acquisition, which includes a 110-bedded hospital with potential to expand to 150 beds, aligns with Fortis’ cluster-focused inorganic growth strategy and adds to its presence in the North West Bengaluru corridor, bringing the company’s operational bed capacity in the city to approximately 1,000. Suguna Hospital, commissioned in 2006, reported revenues of approximately Rs 50 crore in fiscal year 2026.

1 week agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare submitted securities dematerialization certificates to Indian stock exchanges

Fortis Healthcare Limited submitted certificates to the National Stock Exchange of India Limited and BSE Limited on October 13, 2026, pertaining to dematerialized and rematerialized securities for the quarter ended September 30, 2026, as per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018; Kfin Technologies Limited, formerly known as KFin Technologies Private Limited, acted as the Registrar and Transfer Agent for the filings.

3 weeks agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare will halt share trading October 1st pending financial results declaration

Fortis Healthcare Limited will close its trading window for share transactions from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ended September 30, 2026, in accordance with its insider trading policy.

1 month agoCapital Market - Live
Earnings
Earnings
Fortis Healthcare Ltd consolidated sales up 7.63% on year in Q2FY2026

Fortis Healthcare Ltd share price inched up 1.02% to Rs 935.0 after the company's net profit saw a mild growth of 0.59% to Rs 272.8 crore, while revenue from operations improved marginally 7.63% to Rs 2545.03 crore in Q2FY26 over Q1FY26. The market capitalization of Hospital industry group stocks on BSE stood at Rs 5.11 lakh crore, rising 5.20%. It has edged up by 13.41% over last one week and rallied by 31.33% in last one month while the market capitalization of Fortis Healthcare Ltd has slipped by 1.42% and 1.80% in the same period respectively. Profit before tax (PBT) of Fortis Healthcare Ltd stood at Rs 363.18 crore in Q2 FY26, gaining 3.60% year-on-year, and climbing 12.02% quarter-on-quarter. EBITDA came in at Rs 523 crore, easing 9.97% YoY and declining 1.00% sequentially. Total expenses saw a slight increase of 8.98% to Rs 2129.79 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 585.57 crore, increasing 12.45% YoY, while employee benefits expense was at Rs 404.43 crore, soaring 19.06% YoY. For the TTM ended FY26, revenue from operations rose 17.28% to Rs 9127.84 crore, while net profit soared by 31.48% to Rs 1064.19 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 158382% to Rs 2034.32 crore, and PBT witnessed a strong rise of 35.63% to Rs 1365.85 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 1601.46 crore in FY26, as against Rs 1423.93 crore in FY25. Fortis Healthcare Ltd headed higher 6.71% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.64% during the same period.

3 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare to review quarterly results at board meeting on August 6, 2026

Fortis Healthcare Limited will hold a board meeting on Thursday, August 06, 2026, to consider and approve the unaudited financial results (standalone & consolidated) for the quarter ended June 30, 2026, according to a regulatory filing. The company also announced that the trading window for dealing in securities will remain closed until August 08, 2026, following a previous announcement on June 24, 2026.

3 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare fixes record date for final dividend

Fortis Healthcare has fixed 24 July 2026 as record date for payment of final dividend for FY 2026.

3 months agoCapital Market - Live
Corporate
Corporate
Fortis Healthcare to hold AGM

Fortis Healthcare announced that the Annual General Meeting(AGM) of the company will be held on 11 August 2026.

3 months agoCapital Market - Live

Frequently asked questions

  1. The share price of FORTIS as on 6th November 2026 is ₹766.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. The past returns of Fortis Healthcare Ltd (FORTIS) share are
    • Past 1 week: 2.12%
    • Past 1 month: -0.40%
    • Past 3 months: -16.64%
    • Past 6 months: -19.86%
    • Past 1 year: -24.06%
    • Past 3 years: 129.89%
    • Past 5 years: 205.36%

  3. The current dividend yield of Fortis Healthcare Ltd (FORTIS) is 0.13.

  4. Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fortis Healthcare Ltd (FORTIS) is ₹57897.74 Cr as of 6th November 2026.

  5. The 52-week high of Fortis Healthcare Ltd (FORTIS) is ₹1029.90 and the 52-week low is ₹704.95.

  6. The P/E (price-to-earnings) ratio of Fortis Healthcare Ltd (FORTIS) is 54.67. The P/B (price-to-book) ratio is 5.69.

  7. Fortis Healthcare Ltd (FORTIS) belongs to the Health Care sector & Hospitals & Diagnostic Centres sub-sector.

  8. You can directly buy Fortis Healthcare Ltd (FORTIS) shares on Tickertape. Simply sign up, connect your demat account and place your order.